MoldCo
MoldCo is a Boston-based digital health platform founded in 2023 that delivers direct-to-consumer telehealth, lab testing, and prescription treatment for mold exposure illness, using a patented three-phase protocol anchored by founding physician Dr. Ritchie Shoemaker's 30 years of research.
- Company typePrivate
- Founded2023
- HeadquartersBoston, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What MoldCo does
MoldCo is a digital health platform focused on the diagnosis and treatment of mold-related illness, headquartered in Boston and founded in 2023. The company delivers care through a fully remote, direct-to-consumer model that combines telehealth consultations, at-home and clinical lab testing, and prescription medications, anchored by a patented three-phase treatment protocol and a patented VIP peptide therapy. Its clinical authority rests on founding physician Dr. Ritchie Shoemaker's 30 years of mold illness research, reinforced by Medical Director Dr. Scott McMahon, and the protocol incorporates genetic predisposition testing to personalize care.
The product stack is operational rather than algorithmic: a $79-per-month membership provides ongoing clinical access, augmented by $129 video visits, lab panels priced at $56-$199, and prescription medications ranging from $23 to $219 per month, producing an all-in patient cost of $107-$313 per month. Genetic testing is offered as an additional diagnostic layer, intended to identify susceptibility and inform protocol selection. The company exited stealth in December 2024 with a $3M pre-seed round and operates 11-50 employees out of Boston.
MoldCo generates revenue through a combination of recurring membership subscriptions, prescription medication sales, per-visit fees, and lab testing, all sold direct-to-consumer through its own website with no enterprise or payer relationships disclosed. Following a $8M seed round in September 2025 co-led by Cantos and Collaborative Fund, the company has begun scaling beyond its founding geography, opening California and signing a partnership with Monarch Athletic Club in October 2025 as its first external distribution channel.
MoldCo firmographics
Firmographics- Name
- MoldCo
- Legal name
- The Immune Co.
- Website
- https://moldco.com
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- MoldCo is a Boston-based digital health platform founded in 2023 that delivers direct-to-consumer telehealth, lab testing, and prescription treatment for mold exposure illness, using a patented three-phase protocol anchored by founding physician Dr. Ritchie Shoemaker's 30 years of research.
- Ownership category
- akta.pro rank
MoldCo industry classification
Industry- Product category
- Digital Health / Mold Toxicity Care
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421), Pharmacies and Drug Retailers (456110), Packaging and Labeling Services (56191)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Retail-Drug Stores And Proprietary Stores (5912)
- akta.pro primary industry
- Telepharmacy & Prescription Fulfillment Marketplaces (HLALALAF)
- akta.pro secondary industry
- Medication Adherence, Packaging & Fulfillment Services (Blister/Unit-Dose) (HLAFALAJ)
Keywords
Where MoldCo is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
MoldCo business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain
Revenue model
- MoldCo Membership subscription: Recurring monthly subscription for access to the MoldCo platform, unlimited care team messaging, structured recovery program, symptom tracking, and health resources. $79/month base, cancel anytime.
- Prescription medication sales (per phase): Direct charges for prescription medications dispensed via vetted third-party pharmacies and shipped to patients: Colesevelam ($129/mo), EDTA Nasal Spray ($23/mo), VIP Nasal Spray ($219/mo). Charged one phase at a time.
- Virtual provider visits: On-demand 30-minute telehealth provider video visits at $129 each, paid on a per-visit basis on top of membership.
- Lab testing (clinical and environmental): One-time/unit-priced lab tests ordered through the platform. Clinical lab tests from $56 for health panels and from $199 for home/environmental tests, fulfilled by independent CLIA-certified labs.
- Payment facilitation for third-party providers: MoldCo acts as a limited payment collection agent for third-party clinical services (Practitioners, Medical Groups, Pharmacies, Labs), taking a platform/payment facilitation fee on each transaction.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | MoldCo Membership (base platform access) |
| Unit Pricing | Pay-as-you-go | Virtual provider video visit (add-on) |
| Subscription | Monthly | Colesevelam (Phase 1 — Detox binder) |
| Subscription | Monthly | EDTA Nasal Spray (Phase 2 — Clear) |
| Subscription | Monthly | VIP peptide (Phase 3 — Repair) |
| Unit Pricing | Pay-as-you-go | Lab testing (clinical & environmental) |
| Freemium | — | Free mold risk assessment / questionnaire |
Go-to-market motion4 records
Distribution channels5 records
Marketing channels9 records
MoldCo product offering
Product offeringCore offering
MoldCo operates a digital health platform that delivers a patented, three-step mold recovery protocol (Detox, Clear, Repair) based on Dr. Ritchie Shoemaker's three decades of biotoxin research. The membership ($79/month) bundles unlimited care team messaging, monthly provider check-ins, symptom tracking, and access to mold-trained providers via telehealth, with on-demand 30-minute video visits available for $129 each. The protocol is supported by prescription medications (Colesevelam, EDTA nasal spray, and a patented VIP peptide) dispensed through vetted third-party pharmacies, as well as clinical and environmental lab testing fulfilled by CLIA-certified third-party labs.
Product overview
MoldCo offers a unified digital health platform for mold toxicity care built around a single core product, the MoldCo Protocol — a 3-step (Detox, Clear, Repair) recovery program priced at $79/month plus medication costs, paired with access to mold-trained providers and unlimited care team messaging. Supporting products include MoldCo Lab Testing (clinical and environmental lab tests fulfilled by third-party labs and accessed through https://products.moldco.com/) and three prescription medications (Colesevelam for Detox, EDTA Nasal Spray for Clear, and the patented VIP Nasal Spray for Repair) that are dispensed through vetted pharmacies as part of the protocol phases. On top of this, MoldCo offers two free tools to acquire and assess users: the MoldCo Home & Health Questionnaire (a free online risk assessment that produces a risk score) and the free Mold Exposure Guide (a downloadable educational resource on spotting, testing, preventing, and recovering from mold exposure).
Differentiator
Problem solved
Functional benefit
Products and services
- MoldCo Protocol A patented, three-step mold recovery care program (Detox, Clear, Repair) built on Dr. Ritchie Shoemaker's 30 years of biotoxin research. Members receive unlimited care team access, monthly provider check-ins, symptom tracking, and pharmacy-prepared prescription medications shipped to their door. Priced at $79/month plus medication costs, HSA/FSA eligible, cancel anytime.
- MoldCo Lab Testing Evidence-based laboratory testing options ordered through MoldCo's platform, including clinical laboratory tests ordered by licensed Practitioners and Environmental Testing Services for homes. Tests are fulfilled through vetted, accessible third-party (CLIA-certified) laboratories and are available from $56 for health tests and $199 for home tests.
- Colesevelam (Phase 1: Detox binder) A prescription binder used in the MoldCo Protocol's Detox phase to support mold and biotoxin removal. Listed at $129/month and shipped from vetted pharmacies.
- EDTA Nasal Spray (Phase 2: Clear) A prescription nasal spray used in the MoldCo Protocol's Clear phase to break down the defensive biofilm of harmful bacteria so they can be cleared by the body. Listed at $23/month.
- VIP (Vasoactive Intestinal Peptide) Nasal Spray (Phase 3: Repair) MoldCo's patented VIP peptide nasal spray used in the Repair phase to calm inflammation and support healthy immune response. Listed at $219/month and described as a patented peptide offering.
- Virtual Provider Video Visits On-demand 30-minute telehealth provider video visits available to members for $129 each, conducted by mold-trained providers via the MoldCo platform on top of the base membership.
Companies that use MoldCo
Customer profileSegments4 records
Ideal customer profiles4 records
MoldCo technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature6 records
MoldCo partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core and secondary.
- Monarch Athletic ClubcoreOctober 2025 partnership to provide mold toxicity care to Monarch Athletic Club's California membership base, marking MoldCo's expansion into California and into fitness-channel distribution. Combines MoldCo's telehealth, lab testing, and treatment with Monarch's athletic-club audience to make mold detox part of preventative health.
- Dr. Scott McMahoncoreWorld-renowned mold illness expert joined MoldCo as Medical Director in May 2025, anchoring the company's clinical credibility and the Shoemaker Protocol implementation. Hosts the 'Medicine and Miracles' podcast focused on CIRS.
- Dr. Ritchie ShoemakercoreFounding physician of MoldCo; creator of the Shoemaker Protocol used in 30,000+ patients and 40+ peer-reviewed studies that underpin the MoldCo Protocol.
- Immune Co Medical Group PAcoreIndependent physician-owned affiliated clinical practice (a Florida professional association) that employs or contracts with Practitioners who deliver clinical Healthcare Services through MoldCo's Platform; governed by HIPAA and MoldCo's Business Associate Agreement.
- New York Opus Medical Services, P.C.secondaryAffiliated Covered Entity (New York professional corporation) that provides clinical services via MoldCo's Platform under HIPAA and the Notice of Privacy Practices.
- Immune Co Medical Group West PCsecondaryAffiliated Covered Entity (California professional corporation) enabling MoldCo's clinical service expansion into California; bound by the same Notice of Privacy Practices as other affiliated practices.
- Stripe, Inc.coreThird-party payment processor that handles all credit/debit card transactions on MoldCo's Platform, including collection of Membership fees and payment facilitation for Third-Party Providers.
- Google (Google Analytics)secondaryAnalytics provider integrated with moldco.com in service-provider mode; advertising features disabled on health-related pages and Google is prohibited from using any health data for advertising or cross-context behavioral advertising.
- MetasecondaryAnalytics/advertising integration referenced in the Privacy Policy; restricted from collecting or using health-related data for advertising or profiling.
- BrazesecondaryCustomer engagement / messaging platform integrated with moldco.com for service-related communications; restricted from using health data for advertising or independent profiling.
- Vetted third-party pharmaciescoreNetwork of reputable, vetted pharmacies that dispense and ship MoldCo's prescription medications (Colesevelam, EDTA Nasal Spray, VIP) directly to patients; fulfill prescriptions written by Practitioners through the MoldCo Platform.
- CLIA-certified third-party laboratoriescoreIndependent CLIA-certified clinical laboratories and environmental testing labs that perform MoldCo's lab tests (clinical and environmental) and ship collection kits to patients; set their own pricing and are governed by their own terms and privacy practices.
Scale indicators12 records
Recent moves6 records
Expansion highlights5 records
MoldCo competitors and assessment
Company assessmentDirect peers
- Parsley Health: DTC functional and integrative medicine telehealth platform offering memberships with provider visits, lab testing, and personalized care plans. Most comparable to MoldCo in combining a cash-pay subscription, telehealth delivery, and root-cause / chronic-condition framing.
- Forward Health: Membership-based preventive primary-care platform combining tech-enabled in-person and virtual visits, biometric testing, and continuous monitoring. Comparable on the consumer-paid subscription, testing-led, longitudinal-care model MoldCo uses.
- Maven Clinic: Specialty virtual care platform delivering condition-specific (women's/family health) care with provider messaging, video visits, and content resources. Comparable in the specialty, content-led, virtual-clinic model MoldCo uses for mold/CIRS.
- Ciba Health: Root-cause and functional medicine virtual clinic offering memberships, provider visits, and lab testing for chronic conditions. Highly comparable in cash-pay subscription, telehealth delivery, and chronic-condition framing MoldCo uses.
- Eden Health: Virtual-first primary care combining telehealth, in-person visits, and care navigation for chronic and complex conditions. Comparable in blending subscription care with chronic-condition focus and lab-driven protocols.
Broad incumbents
- Hims & Hers Health: Large public telehealth platform selling subscriptions and prescription products direct to consumers across multiple categories. Comparable in DTC subscription + medication + telehealth bundle, but operates at vastly larger scale and across broader indications.
- Ro: Multi-condition DTC telehealth platform offering provider visits, lab testing, and pharmacy fulfillment under brands like Roman and Rory. Highly comparable on the vertically integrated telehealth + lab + pharmacy model and cash-pay consumer motion.
- Teladoc Health: Large incumbent virtual care provider offering telehealth across primary care, mental health, and specialty conditions. Comparable in telehealth delivery and prescription fulfillment, but operates on a B2B/B2B2C payer-funded model rather than MoldCo's cash-pay subscription.
Emerging players
- Solace Health: Virtual care navigation and specialty telehealth platform pairing patients with advocates and providers for complex chronic conditions. Comparable in helping patients navigate specialist care for under-served chronic conditions like CIRS/mold illness.
Others
- Levels Health: DTC metabolic-health subscription combining at-home lab testing (CGM) with software and clinician access. Comparable as a benchmark for the DTC subscription + lab testing + virtual care consumer motion MoldCo uses, though in a different condition area.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
MoldCo social profiles
Digital presenceMoldCo compliance and trust
Trust signalCompliance3 records
MoldCo financial estimates
Financial estimateRevenue estimate
Valuation estimate
MoldCo leadership team
Management profileNumber of profiles
Profiles7 records
MoldCo subsidiaries and ownership
Company hierarchySubsidiaries3 records
MoldCo funding detail
Funding detailFunding overview
Funding rounds2 records
Investors13 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MoldCo M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MoldCo
What does MoldCo do?
MoldCo operates a digital health platform that delivers a patented, three-step mold recovery protocol (Detox, Clear, Repair) based on Dr. Ritchie Shoemaker's three decades of biotoxin research. The membership ($79/month) bundles unlimited care team messaging, monthly provider check-ins, symptom tracking, and access to mold-trained providers via telehealth, with on-demand 30-minute video visits available for $129 each. The protocol is supported by prescription medications (Colesevelam, EDTA nasal spray, and a patented VIP peptide) dispensed through vetted third-party pharmacies, as well as clinical and environmental lab testing fulfilled by CLIA-certified third-party labs.
Is MoldCo a public or private company?
MoldCo is a private company. It is classified as venture growth investor backed and is currently operating.
When was MoldCo founded?
MoldCo was founded in 2023. It employs 11 to 50 people.
Where is MoldCo based?
MoldCo is headquartered in Boston, United States, in the North America region.
How does MoldCo make money?
Five revenue lines are on record. MoldCo Membership subscription is the primary driver. The others are prescription medication sales (per phase), virtual provider visits, lab testing (clinical and environmental) and payment facilitation for third-party providers.
Who are MoldCo's main competitors?
Direct peers on record are Parsley Health, Forward Health, Maven Clinic, Ciba Health and Eden Health. Broad incumbents are Hims & Hers Health, Ro and Teladoc Health. Solace Health is listed as an emerging player. Levels Health is listed as an others.
Does MoldCo have an API?
No public API is recorded for MoldCo.
What industry is MoldCo in?
MoldCo's product category is Digital Health / Mold Toxicity Care. Its primary akta.pro industry code is HLALALAF, Telepharmacy & Prescription Fulfillment Marketplaces, with a secondary code of HLAFALAJ, Medication Adherence, Packaging & Fulfillment Services (Blister/Unit-Dose). Its NAICS code is 42421 and its SIC code is 5122.